Neuroglee Health Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 48

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 9

Neuroglee Health General Information

Description

Developer of a therapeutic device designed to accompany treatment for patients with neurodegenerative diseases. The company's therapeutics and monitoring tools assist in preserving cognition and independence while providing consistent insight into drug efficacy, facilitating accelerated drug development, it also uses cognitive and neurobehavioral mechanisms to monitor and engage users individually, enabling patients to empower themselves with treatment for neurodegenerative diseases.

Contact Information

Website
www.neuroglee.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 Arch Street
  • Floor 08
  • Boston, MA 02110
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech
Corporate Office
  • 101 Arch Street
  • Floor 08
  • Boston, MA 02110
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuroglee Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC Completed Generating Revenue
2. Early Stage VC (Series A) 09-Sep-2021 Completed Generating Revenue
1. Seed Round 03-Dec-2020 $2.46M $2.46M Completed Generating Revenue
To view Neuroglee Health’s complete valuation and funding history, request access »

Neuroglee Health Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed
Seed 266,664 $3 $3 1x $3 15.21%
To view Neuroglee Health’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Neuroglee Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a therapeutic device designed to accompany treatment for patients with neurodegenerative diseases. The comp
Therapeutic Devices
Boston, MA
48 As of 2023

Austin, TX
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuroglee Health Competitors (3)

One of Neuroglee Health’s 3 competitors is BrainCheck, a Venture Capital-Backed company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BrainCheck Venture Capital-Backed Austin, TX
Savonix Formerly VC-backed San Francisco, CA
Neurotrack Venture Capital-Backed Redwood City, CA
You’re viewing 3 of 3 competitors. Get the full list »

Neuroglee Health Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Neuroglee Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022086454-A1 System and method for delivering personalized cognitive intervention Inactive 23-Oct-2020

Neuroglee Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuroglee Health Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
EDBI Venture Capital Minority
Angel (individual) Minority
Openspace Capital Asset Manager Minority
Angel (individual) Minority
2050 Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Neuroglee Health FAQs

  • When was Neuroglee Health founded?

    Neuroglee Health was founded in 2020.

  • Where is Neuroglee Health headquartered?

    Neuroglee Health is headquartered in Boston, MA.

  • What is the size of Neuroglee Health?

    Neuroglee Health has 48 total employees.

  • What industry is Neuroglee Health in?

    Neuroglee Health’s primary industry is Therapeutic Devices.

  • Is Neuroglee Health a private or public company?

    Neuroglee Health is a Private company.

  • What is Neuroglee Health’s current revenue?

    The current revenue for Neuroglee Health is .

  • How much funding has Neuroglee Health raised over time?

    Neuroglee Health has raised $12.5M.

  • Who are Neuroglee Health’s investors?

    EDBI, , Openspace Capital, , and 2050 Capital are 5 of 9 investors who have invested in Neuroglee Health.

  • Who are Neuroglee Health’s competitors?

    BrainCheck, Savonix, and Neurotrack are competitors of Neuroglee Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process